An early lesion in hepatic carcinogenesis: loss of heterozygosity in human cirrhotic livers and dysplastic nodules at the 1p36-p34 region - PubMed (original) (raw)
An early lesion in hepatic carcinogenesis: loss of heterozygosity in human cirrhotic livers and dysplastic nodules at the 1p36-p34 region
M Sun et al. Hepatology. 2001 Jun.
Abstract
Loss of heterozygosity (LOH) of chromosome 1 has been suggested, by karyotyping, to be an initial episode in human hepatocarcinogenesis. However, this alteration has not yet been investigated in cirrhotic nodules (CNs) or dysplastic nodules (DNs). In an initial study from explanted or resected cirrhotic livers, LOH in 1p36-p32 was examined in 31 hepatocellular carcinomas (HCCs), 25 low-grade dysplastic nodules (LGDNs), and 24 high-grade dysplastic nodules (HGDNs). In HCCs, LOH was detected most frequently at loci D1S2843 (1p36.1) (28.6%), D1S513 (1p34.3) (29.2%), and MYCL1 (1p34.1) (28.6%). In HGDN and LGDN, LOH incidences at D1S513 were 11.1% and 13.6%, respectively. To further refine those results and to determine sequential relationships among CN, DN, and HCC, LOH was next studied in an additional 53 HCCs, 56 HGDNs, 30 LGDNs, and 215 CNs from 11 explanted human cirrhotic livers, including 30 "nodule-in-nodule" lesions. Seven markers between D1S2843 (1p36.12) and MYCL1 (1p34.1), and 1 each at D1S484 (1q24.1), IGF2R-3 (6q26), and TP53 (17p13.1) were used. LOH at D1S2843 and D1S513 was detected in HCCs (20.4% and 23.5%, respectively), HGDNs (7.7% and 18.5%), LGDNs (13.6% and 6.9%), and CNs surrounding either HCCs or DNs (7.4% and 8.3%). These results demonstrate that LOH at D1S2843 and D1S513 are early events in human liver carcinogenesis. Data from CN surrounding either HCCs or DN, and also nodule-in-nodule lesions, provide evidence supporting a CN-->DN-->HCC progression. Different deletion patterns from multiple HCCs and DNs suggest independent origins for carcinogenesis in the same individual.
Similar articles
- Molecular changes in hepatocellular dysplastic nodules on microdissected liver biopsies.
Maggioni M, Coggi G, Cassani B, Bianchi P, Romagnoli S, Mandelli A, Borzio M, Colombo P, Roncalli M. Maggioni M, et al. Hepatology. 2000 Nov;32(5):942-6. doi: 10.1053/jhep.2000.18425. Hepatology. 2000. PMID: 11050043 - The expression of transforming growth factor-alpha in cirrhosis, dysplastic nodules, and hepatocellular carcinoma: an immunohistochemical study of 70 cases.
Yeh MM, Larson AM, Campbell JS, Fausto N, Rulyak SJ, Swanson PE. Yeh MM, et al. Am J Surg Pathol. 2007 May;31(5):681-9. doi: 10.1097/PAS.0b013e31802ff7aa. Am J Surg Pathol. 2007. PMID: 17460450 - Clonal analysis of macronodules in cirrhosis.
Paradis V, Laurendeau I, Vidaud M, Bedossa P. Paradis V, et al. Hepatology. 1998 Oct;28(4):953-8. doi: 10.1002/hep.510280409. Hepatology. 1998. PMID: 9755231 - Early hepatocellular carcinoma and dysplastic nodules.
Kojiro M, Roskams T. Kojiro M, et al. Semin Liver Dis. 2005;25(2):133-42. doi: 10.1055/s-2005-871193. Semin Liver Dis. 2005. PMID: 15918142 Review. - Preneoplastic lesions in human hepatocarcinogenesis.
Libbrecht L, Desmet V, Roskams T. Libbrecht L, et al. Liver Int. 2005 Feb;25(1):16-27. doi: 10.1111/j.1478-3231.2005.01016.x. Liver Int. 2005. PMID: 15698394 Review.
Cited by
- CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. Development, growth, and spread: key pathologic and imaging aspects.
Choi JY, Lee JM, Sirlin CB. Choi JY, et al. Radiology. 2014 Sep;272(3):635-54. doi: 10.1148/radiol.14132361. Radiology. 2014. PMID: 25153274 Free PMC article. Review. - Identification of drivers from cancer genome diversity in hepatocellular carcinoma.
Takai A, Dang HT, Wang XW. Takai A, et al. Int J Mol Sci. 2014 Jun 20;15(6):11142-60. doi: 10.3390/ijms150611142. Int J Mol Sci. 2014. PMID: 24955791 Free PMC article. Review. - Clonality and allelotype analyses of focal nodular hyperplasia compared with hepatocellular adenoma and carcinoma.
Cai YR, Gong L, Teng XY, Zhang HT, Wang CF, Wei GL, Guo L, Ding F, Liu ZH, Pan QJ, Su Q. Cai YR, et al. World J Gastroenterol. 2009 Oct 7;15(37):4695-708. doi: 10.3748/wjg.15.4695. World J Gastroenterol. 2009. PMID: 19787833 Free PMC article. - Biliary and reticuloendothelial impairment in hepatocarcinogenesis: the diagnostic role of tissue-specific MR contrast media.
Bartolozzi C, Crocetti L, Lencioni R, Cioni D, Della Pina C, Campani D. Bartolozzi C, et al. Eur Radiol. 2007 Oct;17(10):2519-30. doi: 10.1007/s00330-007-0602-5. Epub 2007 Feb 16. Eur Radiol. 2007. PMID: 17429640 Review. - Rare allelic imbalances, but no mutations of the PRDX1 gene in human hepatocellular carcinomas.
Gisin J, Perren A, Bawohl M, Jochum W. Gisin J, et al. J Clin Pathol. 2005 Nov;58(11):1229-31. doi: 10.1136/jcp.2004.024679. J Clin Pathol. 2005. PMID: 16254121 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous